Medtronic plc, the global leader in healthcare technology, today announced it has doubled both the size of its London office to 25,000 sq ft, and its London workforce to over 200, to focus on the development of AI and digital technologies.

美敦力公司（Medtronic plc），全球医疗技术的领导者，今天宣布将其伦敦办公室的规模扩大了一倍，达到25,000平方英尺，并将伦敦的员工人数增加到200多人，以专注于人工智能和数字技术的开发。

The expansion forms the business’ largest global digital centre for AI and robotics in surgery. It is part of a multi-million-dollar investment in the United Kingdom over five years, building on the company’s existing substantial commitments to the market, including local partnerships in the research and design of robotic-assisted surgery capabilities..

此次扩建形成了该公司在手术领域最大的全球数字中心，专注于人工智能和机器人技术。这是公司五年内在英国数百万美元投资的一部分，建立在其对市场现有的重大承诺之上，包括在机器人辅助手术能力研究和设计方面的本地合作伙伴关系。

This investment reinforces the growing research and development presence of Medtronic in the UK, underlying the company’s long-term commitment to supporting the UK healthcare industry through innovative technologies. This investment aims to strengthen innovation in the UK healthcare, and aligns with the ambitions of the NHS 10-Year Health Plan..

这项投资加强了美敦力在英国日益增长的研发实力，体现了公司通过创新技术长期致力于支持英国医疗保健行业的承诺。该投资旨在加强英国医疗保健领域的创新，并与英国国家医疗服务体系（NHS）的《十年健康计划》目标相一致。

Located in London’s Old Street “Silicon Roundabout”, the

位于伦敦老街“硅环岛”的

Medtronic Centre of Digital Excellence

美敦力数字卓越中心

drives research and development in software for robotic-assisted surgery in the UK and globally. The site brings together some of the UK’s leading medical software engineers, including new software developer roles, to advance digital surgical capabilities and applications, across global healthcare systems..

推动英国及全球机器人辅助手术软件的研发。该基地汇集了英国一些领先的医疗软件工程师，包括新的软件开发人员职位，以提升全球医疗系统中的数字手术能力和应用。

'The future of surgery is increasingly digital. Our investment reflects the significant talent and innovation here in the UK, including in AI, and is a statement of intent to transform healthcare outcomes for surgeons and patients worldwide, said

“手术的未来将愈发数字化。我们的投资反映了英国在人工智能等领域的显著人才和创新能力，也表明了我们旨在改善全球外科医生和患者的医疗结果。”

George Murgatroyd, VP & general manager, Digital Technologies within the Surgical Business, which is part of the Medtronic Medical Surgical Portfolio.

乔治·默加特罗伊德，外科业务部数字技术副总裁兼总经理，该部门隶属于美敦力医疗外科产品组合。

“Medtronic has led technology innovation in medicine for decades, and our significant investment in the era of digitised healthcare positions us as a partner to help shape the UK’s vision for a technology-driven future. Placing ourselves in the beating heart of London’s tech hub, probably the most innovative square mile in Europe, is key to building the future of digitally-enabled healthcare.“.

“几十年来，美敦力一直在医疗技术革新方面处于领先地位，我们对数字化医疗时代的大力投资使我们成为帮助塑造英国技术驱动未来愿景的合作伙伴。将自身置于伦敦科技中心的核心地带，可能是欧洲最具创新力的一平方英里，这对构建数字化医疗的未来至关重要。”

A hub for surgical AI and collaboration

手术人工智能和协作的枢纽

The Medtronic London centre has already designed highly specialised computing and software for operating rooms – now installed in hospitals in over 30 countries worldwide. The team has developed and launched hundreds of AI algorithms to help surgeons automatically access analytics after performing surgery.

美敦力伦敦中心已经为手术室设计了高度专业化的计算和软件系统，目前已被全球30多个国家的医院安装使用。该团队开发并推出了数百种人工智能算法，帮助外科医生在手术完成后自动获取分析数据。

This digital technology supports surgical teams in their planning, learning, and collaboration with other experts around the world - including through secure live streaming. The London centre is central to Medtronic’s surgical robotics innovation – with capabilities in development, including AI-powered decision support capabilities for surgeons whilst they operate, in real-time..

这项数字技术通过安全的实时流媒体支持外科团队进行手术规划、学习并与世界各地的其他专家合作。伦敦中心是美敦力手术机器人创新的核心，具备开发能力，包括为外科医生提供实时的人工智能决策支持功能。

The site also features a mock robotic operating theatre to test new technologies and allow healthcare professionals to engage directly in the future of digitised procedure rooms.

该网站还设有一个模拟机器人手术室，用于测试新技术，并让医疗专业人员直接参与数字化手术室的未来。

Proven track record in UK innovation

在英国创新方面有经验证的业绩记录

There are nearly 60 million soft-tissue surgeries done around the world each year – most still delivered open. Advancing capabilities and access to minimally invasively surgical techniques reduces patient risks and improves recovery.

全球每年进行近 6000 万台软组织手术，其中大多数仍是开放手术。提升微创手术技术的能力和使用率可降低患者风险并改善康复效果。

i,ii,iii,iv

一、二、三、四

Advancing technology improves the delivery of care.

技术进步改善了护理的提供。

'This is a transformative moment for surgical innovation within the NHS,' said

“这是NHS外科创新的变革时刻，”

Professor

教授

Sanjay Purkayastha, consultant general and bariatric surgeon at Imperial College Healthcare NHS Trust

帝国理工学院医疗保健NHS信托的顾问普通外科和减重外科医生Sanjay Purkayastha

. “AI-powered technologies are no longer future concepts in surgery; they are here and will redefine how we care for patients. By working with partners like Medtronic, we can accelerate the adoption of digital tools in the operating theatre and set a new standard for precision, training, and patient outcomes across the NHS.”.

“人工智能技术在手术中已不再是未来的概念；它们已经到来，并将重新定义我们照顾患者的方式。通过与美敦力等合作伙伴的合作，我们可以加速数字工具在手术室中的应用，并为整个英国国家医疗服务体系（NHS）的精准性、培训和患者治疗效果树立新标准。”

In the UK, Medtronic’s AI and robotics footprint includes various hospitals, including Imperial, King’s College, University College London Hospitals, and Guy’s and St. Thomas’:

在英国，美敦力的AI和机器人技术足迹涵盖多家医院，包括帝国理工学院、国王学院、伦敦大学学院医院以及盖伊和圣托马斯医院：

Evidence shows that when using GI Genius over a standard colonoscopy, adenoma detection rates increase up to 14.4% and reduce adenoma miss rates by approximately 50%.

证据表明，与标准结肠镜检查相比，使用GI Genius可将腺瘤检出率提高多达14.4%，并将腺瘤漏检率降低约50%。

v

v

The £2.5m government-funded NAIAD trial with King’s College London

伦敦国王学院参与的耗资250万英镑的政府资助NAIAD试验

vi

vi

- the largest AI gastroenterology trial in the country - involving 4,000 patients across 20 NHS hospitals, utilises the GI Genius™ intelligent endoscopy module.

- 全国规模最大的人工智能胃肠病学试验 - 涉及20家NHS医院的4000名患者，采用了GI Genius™智能内窥镜模块。

The PillCam™ capsule endoscopy system has helped 4 million patients globally

PillCam™ 胶囊内窥镜系统已在全球范围内帮助了 400 万名患者。

vii

七

, by aiding doctors in the identification of bleeding, Crohn’s disease, polyps, and iron deficiency anaemia in the small bowel and colon.

通过帮助医生识别小肠和结肠中的出血、克罗恩病、息肉和缺铁性贫血。

Hugo™ robotic-assisted surgery system now installed in over 30 countries, including in the UK. More broadly, this investment contributes to the UK robotics market, projected to reach $4 billion by 2030

Hugo™ 机器人辅助手术系统现已安装在包括英国在内的30多个国家。更广泛地说，这项投资有助于英国机器人市场的发展，预计到2030年将达到40亿美元。

viii

八

.

。

The Centre of Digital Excellence will enable Medtronic to build on this legacy and drive further critical R&D, innovation and digital technologies for UK healthcare.

数字卓越中心将使美敦力能够在此基础上再接再厉，推动英国医疗保健领域进一步的关键研发、创新和数字技术。

About Medtronic

美敦力公司简介

Bold thinking. Bolder actions. We are Medtronic. Medtronic plc, headquartered in Galway, Ireland, is the leading global healthcare technology company that boldly attacks the most challenging health problems facing humanity by searching out and finding solutions. Our Mission — to alleviate pain, restore health, and extend life — unites a global team of 95,000+ passionate people across more than 150 countries.

大胆思考。更大胆的行动。我们是美敦力。美敦力公司总部位于爱尔兰戈尔韦，是全球领先的医疗技术公司，通过寻找和发现解决方案，勇敢地应对人类面临的最严峻的健康问题。我们的使命——减轻病痛、恢复健康、延长生命——团结了遍布150多个国家的95,000多名充满热情的员工。

Our technologies and therapies treat 70 health conditions and include cardiac devices, surgical robotics, insulin pumps, surgical tools, patient monitoring systems, and more. Powered by our diverse knowledge, insatiable curiosity, and desire to help all those who need it, we deliver innovative technologies that transform the lives of two people every second, every hour, every day.

我们的技术和疗法治疗70种健康状况，包括心脏设备、手术机器人、胰岛素泵、手术工具、患者监测系统等。凭借我们多样化的知识、无尽的好奇心和帮助所有需要帮助的人的愿望，我们提供了创新的技术，每秒、每小时、每一天都在改变两个人的生活。

Expect more from us as we empower insight-driven care, experiences that put people first, and better outcomes for our world. In everything we do, we are engineering the extraordinary. For more information on Medtronic, visit .

期待我们带来更多精彩，因为我们致力于推动以洞察力为导向的护理、以人为本的体验，以及为我们的世界创造更好的成果。在我们所做的每一件事中，我们都在创造非凡。欲了解有关美敦力的更多信息，请访问。

www.Medtronic.com

www.美敦力.com

and follow on LinkedIn.

并在LinkedIn上关注。

Any forward-looking statements are subject to risks and uncertainties such as those described in Medtronic's periodic reports on file with the Securities and Exchange Commission. Actual results may differ materially from anticipated results.

任何前瞻性陈述均受风险和不确定性的影响，例如美敦力向证券交易委员会提交的定期报告中所述的风险和不确定性。实际结果可能与预期结果有重大差异。

Contacts:

联系人：

Laura Moerman

劳拉·穆尔曼

Public Relations

公共关系

+32 476 228902

+32 476 228902

Ryan Weispfenning

瑞安·魏斯芬宁

Investor Relations

投资者关系

+1-612-839-4549

+1-612-839-4549

i

我

Compared to open surgery.

与开放手术相比。

ii

二

Fitch K, Engel T, Bochner A. Cost differences between open and minimally invasive surgery. Managed Care. 2015;24(9):40–48.

Fitch K、Engel T、Bochner A。开放手术与微创手术的成本差异。《管理式医疗》。2015年；24(9):40-48。

iii

iii

Tiwari MM, Reynoso JF, High R, Tsang AW, Oleynikov D. Safety, efficacy, and cost effectiveness of common laparoscopic procedures. Surg Endosc. 2011;25(4):1127-1135.

Tiwari MM, Reynoso JF, High R, Tsang AW, Oleynikov D. 常见腹腔镜手术的安全性、有效性和成本效益。《外科内镜》2011；25（4）：1127-1135。

iv

四

Roumm AR, Pizzi L, Goldfarb NI, Cohn H. Minimally invasive: minimally reimbursed? An examination of six laparoscopic surgical procedures. Surg Innov. 2005;12(3):261–287.

Roumm AR, Pizzi L, Goldfarb NI, Cohn H. 微创：最低报销？对六种腹腔镜外科手术的审查。《外科创新》。2005;12(3):261–287。

v

v

Repici A, Badalamenti M, Maselli R, et al. Efficacy of Real-Time Computer-Aided Detection of Colorectal Neoplasia in a Randomized Trial. Gastroenterology (2020). https://doi.org/10.1053/j.gastro.2020.04.062

Repici A, Badalamenti M, Maselli R, 等。实时计算机辅助检测结直肠肿瘤的随机试验中的有效性。《胃肠病学》（2020）。https://doi.org/10.1053/j.gastro.2020.04.062

vi

vi

https://news.medtronic.com/2023-06-05-Prestigious-NHS-AI-award-paves-way-for-real-world-trial-of-GI-GeniusTM-intelligent-endoscopy-module

https://news.medtronic.com/2023-06-05-声望卓著的NHS人工智能奖项为GI GeniusTM智能内窥镜模块的真实世界试验铺平了道路

vii

七

Internal data, based on shared colonoscopy volumes per facility.

基于每个机构共享的结肠镜检查数量的内部数据。

viii

八

https://mobilityforesights.com/product/uk-medical-robotics-market

https://mobilityforesights.com/product/uk-medical-robotics-market